ARX – Aroa Biosurgery Ltd

🔒

Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $3.99/month

Recommendation Rating

2

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 0.88

Low: 0.31

High: 1.17

Total Analysts: 5

Company Profile

Aroa Biosurgery Limited is a New Zealand-based regenerative medicine company. The Company develops, manufactures and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction using its extracellular matrix (ECM) technology. Its AROA ECM is a platform technology, containing biomaterial complex mix of biological molecules that is building block for range of soft tissue repair products. Its products include Endoform Antimicrobial Restorative Bioscaffold, Endoform Natural Restorative Bioscaffold, Myriad Matrix, Myriad Morcells and Reinforced Bioscaffolds. Its Endoform Antimicrobial Restorative Bioscaffold and Endoform Natural Restorative Bioscaffold are ECM products for the management of acute and chronic wounds. Its Myriad Matrix is used for soft tissue repair, reinforcement and complex wounds, specifically designed to maximize tissue repair while providing versatility and adaptability across a range of surgical applications.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Responses